Huntsman beats Q4 revenue expectations

Reuters
02/18
Huntsman beats Q4 revenue expectations

Overview

  • Specialty chemicals maker's Q4 revenue beat analysts' expectations

  • Company reported wider-than-expected adjusted net loss

  • Adjusted EBITDA for Q4 beat analyst expectations

Outlook

  • Huntsman expects 2026 capital expenditure levels similar to 2025

  • Company prioritizes cash management and controlling fixed costs amid challenging market

  • Huntsman anticipates eventual improvement in chemical market cycle

Result Drivers

  • POLYURETHANES - Lower average selling prices led to decreased revenues, despite increased sales volumes in Americas and Asia

  • PERFORMANCE PRODUCTS - Competitive pressures resulted in lower average selling prices, impacting revenues and adjusted EBITDA

  • ADVANCED MATERIALS - Decreased sales volumes in infrastructure coatings and general industry, offset by favorable currency exchange

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$1.36 bln

$1.34 bln (13 Analysts)

Q4 Adjusted Net Income

Miss

-$63 mln

-$53.23 mln (11 Analysts)

Q4 Net Income

-$96 mln

Q4 Adjusted EBITDA

Beat

$35 mln

$31.25 mln (14 Analysts)

Q4 Gross Profit

$164 mln

Q4 Operating Income

-$59 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 10 "hold" and 4 "sell" or "strong sell"

  • The average consensus recommendation for the diversified chemicals peer group is "buy."

  • Wall Street's median 12-month price target for Huntsman Corp is $11.00, about 16.7% below its February 13 closing price of $13.21

Press Release: ID:nPn6sjDWWa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10